Ferroptosis in Neurovascular Unit of Ischemic Stroke: Multidimensional Regulatory Mechanisms and Targeted Interventions
Frontiers in Bioscience-Landmark · 26.11.2025 · 30 (11)
DOI: 10.31083/fbl40737 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 26.11.2025. Verfasst von Ting Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Services Management, Xi'an Medical University, 710021 Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Ferroptosis, Ischemic Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Project of Shaanxi Key Laboratory of BrainDisorders, Major scientific research project of the "Buchang Cup" Brain-Heart Collaborative Research Fund in 2022, Xi'an Science and Technology Support Project.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke ranks among the leading global causes of death and disability, driven by intricate mechanisms such as neuronal injury, inflammation, and oxidative stress. Emerging as a pivotal player in ischemic stroke progression is ferroptosis—an iron-dependent form of regulated cell death. Its hallmarks—iron metabolic dysregulation and lipid peroxidation—trigger cell membrane disruption and irreversible neuronal damage. Beyond that, ferroptosis intensifies inflammation and compromises the blood–brain barrier (BBB), substantially increasing the impact of ischemic injury. Research indicates that modulating ferroptosis-related molecular pathways could significantly mitigate the pathological progression of ischemic stroke. Based on a systematic search of PubMed, Web of Science, Embase, and Cochrane Library databases (as of April 30, 2025), this review focuses on the progress of research on the mechanisms and treatments of ferroptosis in ischemic stroke over the past five years, aiming to investigate the underlying mechanisms, pathological roles, cross-disease associations, and targeted therapeutic strategies, to lay a theoretical foundation for the development of advanced therapies, and to outline the challenges and future directions of the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Services Management, Xi'an Medical University, 710021 Xi'an, Shaanxi, China.
- Second Clinical Medical College of Shaanxi University of Chinese Medicine, 712046 Xianyang, Shaanxi, China.
- The Third Department of Neurology, The Second Affiliated Hospital of Xi'an Medical University, 710038 Xi'an, Shaanxi, China.
Förderung
- The Project of Shaanxi Key Laboratory of BrainDisorders
- Major scientific research project of the "Buchang Cup" Brain-Heart Collaborative Research Fund in 2022
- Xi'an Science and Technology Support Project
- National Science Foundation Incubation Program of the Second Afffliated Hospital of Xi'an Medical University
- Wu Jieping Medical Foundation Scientific Research Special Grant Program
- Shaanxi College Students' Innovation and Entrepreneurship Training Program
- Major scientific research project of the “Buchang Cup” Brain-Heart Collaborative Research Fund in 2022
- Xi’an Science and Technology Support Project
Zitieren
APA
Wang, T., Zeng, J., Zhang, J., Sun, X., & Jiang, C. (2025). Ferroptosis in Neurovascular Unit of Ischemic Stroke: Multidimensional Regulatory Mechanisms and Targeted Interventions. Frontiers in Bioscience-Landmark, 30(11). https://doi.org/10.31083/fbl40737
Vancouver
Wang T, Zeng J, Zhang J, Sun X, Jiang C. Ferroptosis in Neurovascular Unit of Ischemic Stroke: Multidimensional Regulatory Mechanisms and Targeted Interventions. Frontiers in Bioscience-Landmark. 2025;30(11). doi:10.31083/fbl40737
BibTeX
@article{Wang2025,
author = {Wang, Ting and Zeng, JiaWei and Zhang, JingHao and Sun, XiaoXu and Jiang, Chao},
title = {Ferroptosis in Neurovascular Unit of Ischemic Stroke: Multidimensional Regulatory Mechanisms and Targeted Interventions},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {11},
doi = {10.31083/fbl40737}
}
EUVIMED